alexa Dipeptidyl Peptidase IV (CD26/DPP-IV) Inhibitory And Cryptoprotective Role Of Some Antidiabetic Plants
ISSN: 2155-6156

Journal of Diabetes & Metabolism
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

5th World Congress on Diabetes & Metabolism
November 03-05, 2014 Embassy Suites Las Vegas, USA

Anand Krishna Singh
ScientificTracks Abstracts: J Diabetes Metab
DOI: 10.4172/2155-6156.S1.026
A novel approach for treatment of type- 2 diabetes is based on the incretin gut hormone glucagon-like peptide-1 (GLP-1) and glucose-dependent insulin tropic polypeptide (GIP). GLP-1 is secreted by the gastrointestinal tract in response to food intake to stimulate insulin secretion and reduced postprandial glycaemia. However, these gut hormones (GLP-1 & GIP) are no longer in an active form due degradation by endogenous dipeptidyl peptidase-IV enzyme (DPP-IV) expressed on the surface of various types of cells. Thus, preventing the degradation of the gut hormones by this enzyme became a new approach for therapeutic strategy for type 2 diabetes mellitus and cryptoprotective role also enhance the effect of antioxidant activity to break the free radicals generated by metabolic disease. Plethora of scientific literature is available on the regulation of type 2 diabetes mellitus by herbal extracts. The DPP-IV activity and cytoprotective were studied based on different antioxidant activity assays such as in vitro DPP-IV activity; hepatic lipid per-oxidation; erythrocytes haemolysis inhibition; DPPH radical scavenging efficacy; ferric reducing potential and total phenolic contents at the varying concentrations in some of the antidiabetic plants methanolic extract M. charantia (family Cucurbitaceae), O .sanctum (family Labiate), W.somnifera (family Solanaceae), T. foenum-graecum (family Leguminoceae) and B. purpurea (family Fabaceae). The result of DPP-IV inhibitors activity was showed (51.3.25?0.09%), (62.38?0.12%), (68.39?0.19%), (48.6?0.24%) and (36.9?0.63%) respected and showed some good cytoprotective potential efficacy and can be developed as therapeutic molecules for type 2 diabetes mellitus and also suggested that this plant could be used as an additive in the food industry providing good protection against oxidative damage.
image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version